Elsevier Executive and Leadership Team

Susan Morrison, the President & Chief Executive Officer, Remediation & Testing at Elsevier, directs the strategic vision and operational execution for the Remediation & Testing division. This critical leadership role focuses on enhancing educational outcomes through innovative testing and remediation solutions. Susan Morrison oversees the development and delivery of products that support academic institutions and professional certification bodies, ensuring alignment with industry standards and evolving educational needs. The President & Chief Executive Officer, Remediation & Testing drives initiatives aimed at improving learning efficacy and supporting career development for individuals. This involves close collaboration with product teams, educators, and industry experts to refine offerings and expand market reach. By focusing on evidence-based approaches, Morrison's leadership ensures that Elsevier's Remediation & Testing services provide significant value, helping users manage their learning journeys more effectively and achieve their professional goals.

Jan Herzhoff, the President, Health Markets at Elsevier, leads the strategic direction and operational performance of Elsevier's health market segment. This executive role focuses on advancing clinical outcomes and improving patient care through evidence-based content and analytics. Jan Herzhoff oversees the development and deployment of solutions that support healthcare professionals throughout the patient journey, ensuring seamless integration into clinical workflows. The President, Health Markets drives innovation in healthcare information delivery, working to make complex data accessible and actionable for clinicians and researchers. This involves fostering strong relationships with healthcare providers, institutions, and technology partners globally. Herzhoff's leadership is crucial for expanding Elsevier's impact in the health sector, enabling more efficient healthcare delivery and supporting medical breakthroughs. The strategic initiatives under this leadership aim to enhance the quality and accessibility of health information worldwide.

Omry Bigger, the President, Clinical Solutions at Elsevier, directs the strategy and operations for the company's clinical solutions portfolio. This leadership position is focused on delivering advanced analytics and evidence-based content to enhance clinical decision-making and improve patient care pathways. Omry Bigger oversees the development, delivery, and market adoption of solutions designed to support healthcare professionals in managing patient journeys effectively. The President, Clinical Solutions drives innovation by integrating cutting-edge technologies with deep clinical insights, ensuring that Elsevier's offerings meet the evolving needs of the healthcare industry. This involves close collaboration with clinical experts, technology teams, and healthcare organizations to refine product offerings and expand their reach. Bigger's strategic guidance is essential for strengthening Elsevier's position as a key partner in advancing healthcare quality and efficiency globally.

Lin Li, the President, Greater (China) at Elsevier, directs the company's strategic operations and market expansion within the Greater China region. This leadership role is pivotal in adapting Elsevier's global mission to the specific dynamics of the Chinese market, focusing on advancing science and health. Lin Li oversees the development and execution of strategies that enhance the delivery of evidence-based content and analytics to researchers, clinicians, and institutions in China. The President, Greater (China) works to foster strong local partnerships and ensure that Elsevier's solutions effectively support scientific discovery and improve clinical outcomes within the region. This involves navigating the unique regulatory and market landscape to drive growth and impact. Li's leadership is crucial for strengthening Elsevier's presence and contribution to the scientific and healthcare communities in Greater China, ensuring efficient management of work and facilitating breakthroughs.

Jill Luber, the Chief Technology Officer at Elsevier, directs the company's technological vision and execution. Overseeing a team of over 1,500 technologists, Jill Luber drives the development and implementation of cutting-edge analytics solutions. This leadership role focuses on leveraging advanced technologies to create platforms that facilitate scientific discovery and improve healthcare delivery. By ensuring robust and scalable technological infrastructure, the Chief Technology Officer supports Elsevier's mission to make analysis easier for professionals in science and medicine. This involves managing the entire technology stack, from data architecture to software development, ensuring alignment with business objectives and market demands. The Chief Technology Officer's strategic direction is crucial for maintaining Elsevier's competitive edge in the information analytics sector, enabling more efficient research and better patient care outcomes.

Lee Elshbe, the Chief of Staff at Elsevier, provides strategic support and operational coordination across key initiatives. This role involves facilitating communication and alignment between executive leadership and various departments, ensuring smooth execution of company-wide strategies. The Chief of Staff works to optimize operational efficiency and drive key projects to completion, acting as a central point for information flow and problem-solving. Lee Elshbe's responsibilities include managing executive priorities, preparing strategic briefings, and ensuring that operational plans directly support Elsevier's mission of advancing science and health. This position requires a deep understanding of the company's business model and market dynamics to effectively translate strategic goals into actionable plans. The Chief of Staff's contribution is vital for maintaining organizational momentum and achieving critical business objectives.

Christina Valimaki, the Chief Marketing Officer, Elsevier Corporate Markets at Elsevier, spearheads marketing strategies for the corporate sector. This leadership position focuses on enhancing Elsevier's brand presence and driving market penetration within its corporate client base. Christina Valimaki oversees the development and execution of integrated marketing campaigns designed to communicate the value of Elsevier's analytics solutions to businesses. The Chief Marketing Officer, Elsevier Corporate Markets ensures that marketing efforts directly support revenue growth and customer acquisition goals. This involves deep collaboration with sales and product development teams to align messaging with market needs and product offerings. By focusing on evidence-based content and analytics, Christina Valimaki's marketing initiatives aim to position Elsevier as an indispensable partner for organizations seeking to improve clinical outcomes and manage work efficiently. The strategic impact of this role is critical for expanding Elsevier's reach and influence in the global information analytics landscape.

Melinda Lee, the Chief of Staff ( Health Markets, APAC) at Elsevier, provides critical operational and strategic support for health market initiatives across the Asia-Pacific region. This role is instrumental in ensuring the effective execution of strategies within this key geographic area. Melinda Lee facilitates cross-functional collaboration and drives key projects, ensuring alignment with Elsevier's global mission to improve health outcomes. The Chief of Staff ( Health Markets, APAC) works closely with regional leadership to address market-specific challenges and opportunities, optimizing operational efficiency and resource allocation. Lee's responsibilities include managing executive priorities, coordinating communications, and supporting the strategic development of health market solutions tailored for the APAC region. This position requires a nuanced understanding of regional healthcare landscapes and regulatory environments to effectively support Elsevier's growth and impact in Asia-Pacific.

Mikhail Vaysbukh, the Chief People Officer & Global Senior VP, Clinical Innovation & Solution Delivery at Elsevier, leads human capital strategy and oversees critical clinical innovation initiatives. This dual role focuses on cultivating a high-performing workforce while driving the development and implementation of advanced clinical solutions. Mikhail Vaysbukh is responsible for attracting, developing, and retaining talent across the organization, ensuring that Elsevier has the expertise needed to achieve its mission. Concurrently, this executive champions clinical innovation, guiding the delivery of solutions that improve patient outcomes and streamline healthcare processes. The Chief People Officer & Global Senior VP, Clinical Innovation & Solution Delivery ensures that people strategies are aligned with business objectives and that clinical solutions effectively address market needs. This comprehensive leadership ensures both organizational strength and impactful product development in the science and health sectors.